Regulation of Vascular Endothelial Growth Factor, VEGF, Gene Promoter by the Tumor Suppressor, WT1

Overview

Journal Front Biosci

Specialty Biology

Date 2006 Nov 28

PMID 17127464

Citations 26

Authors

Julie Hanson

Jacquelyn Gorman

Jennifer Reese

Gail Fraizer

Affiliations

Soon will be listed here.

Abstract

Understanding angiogenesis and growth control is central for elucidating prostate tumorigenesis. However, the mechanisms of activation of the angiogenic gene, vascular endothelial growth factor (VEGF) are complex and its regulation in prostate cancer is not well understood. In previous studies, VEGF expression levels were correlated with altered levels of the zinc finger transcription factor, WT1. Since the VEGF promoter has several potential WT1 binding sites and WT1 regulates many growth control genes, here we assessed whether WT1 might also regulate VEGF transcription. Using transfection and DNA binding assays, functional WT1 binding sites were localized within the proximal VEGF promoter. Transfection of the DDS-WT1 (R394W) zinc finger mutant had no significant effect on VEGF-luciferase reporter activity, suggesting that an intact zinc finger DNA binding domain was required. Interestingly, WT1-mediated regulation of VEGF reporter constructs varied in different cell types. In androgen-responsive, LNCaP prostate cancer cells, hormone treatment enhanced WT1-mediated activation of the VEGF promoter constructs. Overall, these results suggest that WT1 transcriptionally regulates VEGF through interaction of its zinc finger DNA binding domain with the proximal GC-rich VEGF promoter. These findings may shed light on the role of WT1 in angiogenesis and prostate cancer progression.

Citing Articles

Regulation of Mesothelial Cell Fate during Development and Human Diseases.

Taniguchi T, Tomita H, Kanayama T, Mogi K, Koya Y, Yamakita Y Int J Mol Sci. 2022; 23(19).

PMID: 36233262 PMC: 9569588. DOI: 10.3390/ijms231911960.

Every Beat You Take-The Wilms' Tumor Suppressor WT1 and the Heart.

Wagner N, Wagner K Int J Mol Sci. 2021; 22(14).

PMID: 34299295 PMC: 8306835. DOI: 10.3390/ijms22147675.

Expression and prognostic analyses of SCAMPs in pancreatic adenocarcinoma.

Mao F, Duan H, Allamyradov A, Xin Z, Du Y, Wang X Aging (Albany NY). 2021; 13(3):4096-4114.

PMID: 33493138 PMC: 7906166. DOI: 10.18632/aging.202377.

miR-361-5p Mediates SMAD4 to Promote Porcine Granulosa Cell Apoptosis through VEGFA.

Ma M, Zhang J, Gao X, Yao W, Li Q, Pan Z Biomolecules. 2020; 10(9).

PMID: 32899767 PMC: 7563248. DOI: 10.3390/biom10091281.

Clinical development of targeted and immune based anti-cancer therapies.

Seebacher N, Stacy A, Porter G, Merlot A J Exp Clin Cancer Res. 2019; 38(1):156.

PMID: 30975211 PMC: 6460662. DOI: 10.1186/s13046-019-1094-2.

References

Brown T, Rothwell S, Migeon C . Comparison of methyltrienolone and dihydrotestosterone binding and metabolism in human genital skin fibroblasts. J Steroid Biochem. 1981; 14(10):1013-22. DOI: 10.1016/0022-4731(81)90209-0. View

Rauscher 3rd F, Morris J, Tournay O, Cook D, Curran T . Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science. 1990; 250(4985):1259-62. DOI: 10.1126/science.2244209. View

Madden S, Cook D, Morris J, Gashler A, Sukhatme V, Rauscher 3rd F . Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science. 1991; 253(5027):1550-3. DOI: 10.1126/science.1654597. View

Pelletier J, BRUENING W, Kashtan C, MAUER S, Manivel J, Striegel J . Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell. 1991; 67(2):437-47. DOI: 10.1016/0092-8674(91)90194-4. View

Folkman J, Shing Y . Angiogenesis. J Biol Chem. 1992; 267(16):10931-4. View

Drummond I, Madden S, Bell G, Sukhatme V, Rauscher 3rd F . Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science. 1992; 257(5070):674-8. DOI: 10.1126/science.1323141. View

Wang Z, Madden S, Deuel T, Rauscher 3rd F . The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J Biol Chem. 1992; 267(31):21999-2002. View

Gashler A, Bonthron D, Madden S, Rauscher 3rd F, Collins T, Sukhatme V . Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. Proc Natl Acad Sci U S A. 1992; 89(22):10984-8. PMC: 50467. DOI: 10.1073/pnas.89.22.10984. View

Armstrong J, Pritchard-Jones K, Bickmore W, Hastie N, Bard J . The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech Dev. 1993; 40(1-2):85-97. DOI: 10.1016/0925-4773(93)90090-k. View

10.

Kreidberg J, Sariola H, LORING J, Maeda M, Pelletier J, Housman D . WT-1 is required for early kidney development. Cell. 1993; 74(4):679-91. DOI: 10.1016/0092-8674(93)90515-r. View

11.

Werner H, Rauscher 3rd F, Sukhatme V, Drummond I, Roberts Jr C, LeRoith D . Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. J Biol Chem. 1994; 269(17):12577-82. View

12.

Dey B, Sukhatme V, Roberts A, Sporn M, Rauscher 3rd F, Kim S . Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product. Mol Endocrinol. 1994; 8(5):595-602. DOI: 10.1210/mend.8.5.8058069. View

13.

Englert C, Hou X, Maheswaran S, Bennett P, Ngwu C, Re G . WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J. 1995; 14(19):4662-75. PMC: 394563. DOI: 10.1002/j.1460-2075.1995.tb00148.x. View

14.

Hewitt S, Hamada S, McDonnell T, Rauscher 3rd F, Saunders G . Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1. Cancer Res. 1995; 55(22):5386-9. View

15.

Fraizer G, Patmasiriwat P, Zhang X, Saunders G . Expression of the tumor suppressor gene WT1 in both human and mouse bone marrow. Blood. 1995; 86(12):4704-6. View

16.

Quandt K, Frech K, Karas H, Wingender E, Werner T . MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 1995; 23(23):4878-84. PMC: 307478. DOI: 10.1093/nar/23.23.4878. View

17.

Reddy J, Licht J . The WT1 Wilms' tumor suppressor gene: how much do we really know?. Biochim Biophys Acta. 1996; 1287(1):1-28. DOI: 10.1016/0304-419x(95)00014-7. View

18.

Johnstone R, See R, Sells S, Wang J, Muthukkumar S, Englert C . A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1. Mol Cell Biol. 1996; 16(12):6945-56. PMC: 231698. DOI: 10.1128/MCB.16.12.6945. View

19.

Ferrara N . The biology of vascular endothelial growth factor. Endocr Rev. 1997; 18(1):4-25. DOI: 10.1210/edrv.18.1.0287. View

20.

Dong G, Rajah R, Vu T, Hoffman A, Rosenfeld R, Roberts Jr C . Decreased expression of Wilms' tumor gene WT-1 and elevated expression of insulin growth factor-II (IGF-II) and type 1 IGF receptor genes in prostatic stromal cells from patients with benign prostatic hyperplasia. J Clin Endocrinol Metab. 1997; 82(7):2198-203. DOI: 10.1210/jcem.82.7.4067. View